The FT Asia Pharma-Healthcare Summit 2015 is dedicated to regional trends in health economics and supporting investment.
The FT Asia Pharma-Healthcare Summit 2015 covers topics such as:
- The implications of universal healthcare coverage for different stakeholders
- The health economics environment throughout Asia
- Representatives from government agencies with the power to influence policy
- Regulatory and financial challenges for market access in different countries
- Opportunities for investment in innovation and clinical development
- Best practises for interaction between pharma and healthcare providers
The FT Asia Pharma-Healthcare Summit 2015 brings together senior attendees from:
- Medical devices, medical technology, instrumentation and diagnostics companies
- Pharmaceutical and biotechnology companies
- Regulatory agencies and health technology assessment bodies
- Health insurers, government and private health service providers
- Patient representative organisations, health NGOs and social media consultancies
- Investment banks and private equity firms
- Renowned academic institutions